The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. Pharmaceutical companies brace for the upcoming Trump administration. Teva ...

1 Day TEVA 1.11% DJIA 0.78% S&P 500 1.00% Health Care/Life Sciences 66.70% ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $30.00. The company’s shares ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The latest release is from Bettinardi Golf, which unveiled its new HLX 6.0 forged wedges. The HLX 6.0 are the latest wedges from a company that made its name by crafting precision-milled putters.

Cobra continues to build on an already impressive 2025 lineup of products with the introduction of the new KING and KING X wedges. Here are four things to know about the new Cobra wedges.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...